secwatch.observer — SEC 8-K summary
======================================

Issuer:     CDT Equity Inc. (CDT)
CIK:        0001896212
Form:       8-K
Filed at:   2026-01-02T23:59:59+00:00
Accession:  0001493152-26-000143
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CDT enters consulting pacts with Thesprogen and NJS; issues 213,288 shares for $305k in services
--------------------------------------------------------------------------------

- Thesprogen will evaluate AZD1656 pre-clinical data and optimize development strategies; 6-month term, $155k fee paid in 108,392 shares.
- NJS to identify out-licensing partners for solid-form patent portfolio; $150k retainer in 104,896 shares plus 8% commission on transactions.
- Shares issued in unregistered transaction under Regulation D; no registration rights granted.
- Press release highlights NJS engagement to accelerate licensing and royalty-based deals for solid-form assets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1896212/000149315226000143/0001493152-26-000143-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1896212/000149315226000143/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-000143

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer